2019 - ESSA Pharma

Date	Title
October 28, 2019	ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 18, 2019	ESSA Announces Changes to its Board of Directors
October 7, 2019	ESSA Pharma Board of Directors Approves Stock Option Plan RSU Plan and Option Grants
September 28, 2019	ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress
September 19, 2019	ESSA to Present at Ladenburg Thalmann Healthcare Conference
September 5, 2019	ESSA Pharma to Present at H.C. Wainwright 21st Annual Global Investment Conference
August 27, 2019	ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Process of US$36 Million
August 23, 2019	ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement
August 14, 2019	ESSA Pharma Provides Corporate Update and Reports Financial Results for the Fiscal Third Quarter Ended June 20, 2019
July 31, 2019	ESSA Announces that the Scheme of Arrangement with Realm Therapeutics has become Effective